Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Central Admixture Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc. Recalls

All product recalls associated with Central Admixture Pharmacy Services, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

719

Past Year

2

Class I (Serious)

47

Most Recent

Jul 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 121–140 of 719 recalls

Neonatal TPN Starter Bag (Central Admixture) – sterility issue (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Norepinephrine IV Bag (Central Admixture) – sterility issue (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

1...5 678 9...36

Page 7 of 36Next

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Glycopyrrolate Syringe (Central Admixture) – sterility issue (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Diltiazem IV Bag (Central Admixture) – sterility risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Oxytocin IV Bag (Central Admixture) – sterility uncertainty (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Succinylcholine Syringe (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution (Central Admixture) – sterility risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Phenylephrine IV Bag (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag (Central Admixture) – sterility concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution (Central Admixture) – sterility risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution Low Potassium (Central Admixture) – Sterility Risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag 3% (Central Admixture) – Sterility Concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Phenylephrine IV Bag (Central Admixture) – Sterility Concern (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution High Potassium (Central Admixture) – Sterility Risk (2023)

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Class IIModerate

FDAJul 14, 2023Nationwide• Central Admixture Pharmacy Services, Inc.